Phillies Fortify Bullpen with Acquisition of Jordan Romano
Amidst a bustling offseason, the Philadelphia Phillies have made a pivotal addition to their bullpen, signing former Toronto Blue Jays closer Jordan Romano. In what can be seen as a strategic move to bolster their pitching prowess, the Phillies have agreed to a one-year contract with Romano, valued at over $7.75 million.
The 31-year-old Romano arrives to the City of Brotherly Love after being non-tendered by the Blue Jays, a decision likely influenced by Romano's recent struggles on the mound. An elbow injury plagued his final season in Toronto, leading to surgery that impacted his performance. In that challenging season, Romano recorded a 6.59 ERA and a 1.46 WHIP across 15 appearances, statistics that starkly contrast with his stellar performance from 2019 to 2021.
During those peak years, Romano demonstrated his capability as a dominant force in the bullpen, achieving a commendable 2.37 ERA and a 1.09 WHIP. Over that stretch, he amassed 230 strikeouts in 186 innings, establishing himself as a formidable closer in the league.
With the departure of Carlos Estévez, who is now a free agent, the Phillies were eager to find a seasoned replacement to anchor their bullpen. Romano’s acquisition signifies the Phillies’ intent to remain competitive and maintain game flexibility with a trusted late-inning arm.
Reinforcements in the Bullpen
Romano won't be alone in shouldering the bullpen responsibilities for the Phillies. He is expected to receive significant support from a mix of experienced and rising talents. Right-handed pitchers Orion Kerkering and José Ruiz, alongside left-hander Matt Strahm, are all poised to play key roles in closing out games. Strahm, in particular, had an outstanding 2024 season, bringing consistency and reliability to the Phillies' bullpen, which they will hope can continue with Romano on board.
Additionally, Tanner Banks is expected to contribute effectively, especially towards the end of games based on his performance late last season. The bullpen's depth is further expanded with José Alvarado, although his last season presented challenges. Alvarado saw his ERA climb from a remarkable 1.74 in 2023 to 4.09, coupled with a decline in strikeout rates and a rise in walk rates. Restoring Alvarado’s form could prove pivotal to the overall effectiveness of the Phillies’ bullpen strategy.
A Calculated Bet on Recovery
Signing Romano is undeniably a calculated risk for Philadelphia. The Phillies are banking on his recovery and ability to return to peak form following his surgery. If Romano can replicate his pre-injury performance, the Phillies stand to gain substantially from this acquisition. His presence brings not only individual skill but also leadership and experience that could galvanize the bullpen unit.
The challenge, however, lies in his transition and adaptation to a new environment post-injury. Ensuring his health and maintaining a consistent performance level will be crucial to justify the investment the Phillies have made in him. With the support of his new teammates and the medical staff, Romano has the opportunity to turn this new chapter into a successful narrative.
In securing Jordan Romano, the Phillies are adding depth and talent to an already promising bullpen setup. With their sights set on strengthening their postseason prospects, Romano's ability to bounce back could be a game-changer. As the team prepares for the season ahead, all eyes will be on Romano and how he integrates into the Phillies' pitching roster.